Rheumatology

The Rheumafacts study has found that in about half of European countries, patients do not have full access to modern medication and reimbursement for non-pharmacological treatments.

The presence of patient-reported residual symptoms during inactive disease or low disease activity is associated with an increased flare risk in people with axial spondyloarthritis.

Children of mothers who have undergone fertility treatment may have a higher risk for developing juvenile idiopathic arthritis.

Patients with psoriatic arthritis treated with ixekizumab have a higher chance of remission than those given interleukin-12/23 and interleukin-23 inhibitors.

Both patients with rheumatic diseases and healthcare professionals find social robots potentially valuable in outpatient settings, especially for information delivery and patient education support.

A physiotherapist-led, work-focused intervention did not lead to better work-related outcomes in people with rheumatoid arthritis or axial spondyloarthritis, but it may prove to be cost-effective.

Women with worsening chronic kidney disease have an increased risk for emergently treated hypocalcemia after treatment with the drug denosumab.

Transitioning from denosumab to zoledronate leads to greater reductions in lumbar spine but not total hip or femoral neck BMD than continuing with denosumab.

Exposure to TNF inhibitors is linked to a 36% higher risk for inflammatory CNS diseases relative to conventional therapies.

Duration of diabetes and other diabetes-related factors are associated with the likelihood of developing Charcot foot in patients with type 1 or type 2 diabetes.

Data analysis finds that insulin resistance is linked to 31 diseases, including sleeps disorders, bacterial infections and pancreatitis.

Combining exercise with liraglutide leads to clinically relevant weight loss while maintaining bone mineral density in people with obesity.

Women with osteopenia treated with zoledronate for 6 years continue to have a reduced risk for nonvertebral fracture, 3.5 years after their last infusion.